[Vasoactive combination treatment in cerebrovascular sclerosis].
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D007294:Inositol / Q000627:therapeutic use; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D004983:Ethanolamines; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D007294:Inositol
Zur vasoaktiven Kombinationsbehandlung bei zerebraler Gefässsklerose.